Physician

Absar Ahmed Qureshi, MD

According to 2025 Medicare claims, Absar Qureshi, MD (NPI: 1134270309) practices internal medicine in the Beaumont-Port Arthur, TX market, with the plurality of this provider's patient population coming from Jefferson, TX. This provider's primary affiliated billing organization is RHG OF TEXAS PA (NPI: 1013734243; TIN: 994816352) and primary practice location at 77706-2525. Qureshi is affiliated with the CareMax Accountable Care Network, LLC (ACO ID: A5080) and APA ACO Inc. (ACO ID: D0215), participating under both the MSSP and REACH models.

Qureshi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 160 traditional Medicare patients, billed 881 HCPCS/CPT codes, and received $33,397 in Medicare payments. The top billing code was 99222 (Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes). Part D data shows 6,625 prescription claims across 610 beneficiaries totaling $477,640 in drug costs, led by Ozempic (Semaglutide). DME data shows 48 claims. Open Payments data shows 6 records totaling $106. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $131,537 to $33,397. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $20,690 and ending at $8,783.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	548	35,976	$131,537
2016	592	48,331	$146,289
2017	698	15,437	$167,796
2018	604	5,769	$152,648
2019	713	8,839	$185,808
2020	498	3,918	$128,374
2021	377	2,276	$104,690
2022	277	1,917	$79,257
2023	244	1,988	$88,629
2024	160	881	$33,397

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	654	10,767	$673,030
2016	570	12,186	$730,886
2017	682	11,405	$694,185
2018	619	7,438	$439,757
2019	703	6,912	$452,236
2020	699	7,170	$459,059
2021	683	7,256	$495,156
2022	679	7,003	$534,799
2023	678	7,076	$615,902
2024	610	6,625	$477,640

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	62	195	$3,108
2016	28	201	$3,189
2017	11	159	$8,348
2018	N/R	105	$5,387
2019	N/R	161	$7,545
2020	N/R	111	$6,027
2021	N/R	17	$290
2022	N/R	129	$6,702
2023	N/R	98	$6,313
2024	N/R	48	$3,911

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	37	40	$87
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	64	132	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	55	135	$53
80053	Blood test, comprehensive group of blood chemicals	43	57	$10
36415	Insertion of needle into vein for collection of blood sample	50	73	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	63	2,714	$81,886
Eliquis	Apixaban	85	3,957	$74,756
Jardiance	Empagliflozin	23	1,890	$31,804
Xarelto	Rivaroxaban	19	1,440	$26,986
Mounjaro	Tirzepatide	20	560	$20,042

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	11	$2,022
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	26	$1,800
E0570	Nebulizer, with compressor	Y	N/R	11	$89

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$106	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Absar Ahmed Qureshi, MD?

Tedicare shows public-source Medicare data for Absar Ahmed Qureshi, MD (NPI 1134270309), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Absar Ahmed Qureshi, MD have ACO affiliation data?

Absar Ahmed Qureshi, MD is shown with ACO affiliation data for CareMax Accountable Care Network, LLC (MSSP, ACO ID A5080) and APA ACO Inc. (REACH, ACO ID D0215).

What billing organization is linked to Absar Ahmed Qureshi, MD?

Absar Ahmed Qureshi, MD is linked to RHG OF TEXAS PA (billing NPI 1013734243) in the available physician profile data.

Does Absar Ahmed Qureshi, MD have Open Payments data?

Absar Ahmed Qureshi, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.